Pfizer will appeal court decision regarding Celebrex reissue patent
12 March 2014 | By Pfizer
Pfizer Inc. confirmed that the United States District Court for the Eastern District of Virginia granted summary judgment invalidating the reissue patent, covering methods of treating osteoarthritis and other approved conditions with celecoxib...